Proton MR Spectroscopy in Wilson Disease: Analysis of 36 Cases

References

1. ↵
   Walshe JM. Wilson’s disease. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Extrapyramidal Disorders. New York: Elsevier Science;1986 :223–238
2. ↵
   Frydman M, Bonne-Tamir B, Farrer LA, et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proc Natl Acad Sci U S A 1985;82:1819–1821

   Abstract/FREE Full Text
3. ↵
   Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine (Baltimore) 1992;71:139–164

   PubMed
4. ↵
   Brewer GJ, Fink JK, Hedera P. Diagnosis and treatment of Wilson’s disease. Semin Neurol 1999;19:261–270

   PubMedWeb of Science
5. ↵
   Magalhaes AC, Caramelli P, Menezes JR, et al. Wilson’s disease: MRI with clinical correlation. Neuroradiology 1994;36:97–100

   CrossRefPubMed
6. ↵
   Prayer L, Wimberger D, Kramer J, Grimm G, Oder W, Imhof H. Cranial MRI in Wilson’s disease. Neuroradiology 1990;32:211–214

   CrossRefPubMed
7. ↵
   Aisen AM, Martel W, Gabrielsen TO, et al. Wilson disease of the brain: MR imaging. Radiology 1985;157:137–141

   PubMedWeb of Science
8. ↵
   Thuomas KA, Aquilonius SM, Bergstrom K, Westermark K. Magnetic resonance imaging of the brain in Wilson’s disease. Neuroradiology 1993;35:134–141

   CrossRefPubMed
9. ↵
   Nazer H, Brismar J, al-Kawi MZ, Gunasekaran TS, Jorulf KH. Magnetic resonance imaging of the brain in Wilson’s disease. Neuroradiology 1993;35:130–133

   CrossRefPubMed
10. ↵
    Cancado EL, Barbosa ER, Dias MA. Doenca de Wilson. In: Gayotto LCC, Alves VAF, eds. Doencas do Figado e das Vias Biliares. Sao Paulo: Editora Atheneu;2001 :377–391
11. ↵
    Castillo M, Kwock L, Scatliff J, Mukherji SK. Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. Magn Reson Imaging Clin N Am 1998;6:1–20

    PubMed
12. ↵
    Wang ZJ, Zimmerman RA. Proton MR spectroscopy of pediatric brain metabolic disorders. Neuroimaging Clin N Am 1998;8:781–807

    PubMed
13. ↵
    Van den Heuvel AG, Van der Grond J, Van Rooij LG, Van Wassenaer-van Hall HN, Hoogenraad TU, Mali WP. Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy. Radiology 1997;203:539–543

    PubMed
14. ↵
    Alanen A, Komu M, Penttinen M, Leino R. Magnetic resonance imaging and proton MR spectroscopy in Wilson’s disease. Br J Radiol 1999;72:749–756

    Abstract
15. ↵
    Jayasundar R, Sahani AK, Gaikwad S, Singh S, Behari M. Proton MR spectroscopy of basal ganglia in Wilson’s disease: case report and review of literature. Magn Reson Imaging 2002;20:131–135

    PubMed
16. ↵
    Kraft E, Trenkwalder C, Then Bergh F, Auer DP. Magnetic resonance proton spectroscopy of the brain in Wilson’s disease. J Neurol 1999;246:693–699

    PubMed
17. ↵
    Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35–43

    CrossRefPubMedWeb of Science
18. ↵
    Mierisova S, van den Boogaart A, Tkac I, Van Hecke P, Vanhamme L, Liptaj T. New approach for quantitation of short echo time in vivo 1H MR spectra of brain using AMARES. NMR Biomed 1998;11:32–39

    CrossRefPubMedWeb of Science
19. ↵
    Grodd W, Krageloh-Mann I, Klose U, Sauter R. Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. Radiology 1991;181:173–181

    PubMedWeb of Science
20. ↵
    Danielsen ER, Ross B. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York: Marcel Dekker;1999 :34
21. ↵
    King AD, Walshe JM, Kendall BE, et al. Cranial MR imaging in Wilson’s disease. AJR Am J Roentgenol 1996;167:1579–1584

    PubMedWeb of Science
22. ↵
    van Wassenaer-van Hall HN, van den Heuvel AG, Algra A, Hoogenraad TU, Mali WP. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 1996;198:531–536

    PubMedWeb of Science
23. ↵
    Cumings JN. Trace metals in the brain and in Wilson’s disease. J Clin Pathol 1968;21:1–7

    FREE Full Text
24. ↵
    Fu L, Matthews PM, De Stefano N, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 1998;121:103–113

    Abstract/FREE Full Text
25. ↵
    Cumings JN. The copper and iron content of brain and liver in the normal and in hepatolenticular degeneration. Brain 1948;71:410–415

    FREE Full Text
26. ↵
    Lam WW, Wang ZJ, Zhao H, et al. 1H MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis. Neuroradiology 1998;40:315–323

    CrossRefPubMedWeb of Science
27. ↵
    Tedeschi G, Bertolino A, Righini A, et al. Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology 1995;45:1384–1391

    Abstract/FREE Full Text
28. ↵
    Choi CG, Ko TS, Lee HK, Lee JH, Suh DC. Localized proton MR spectroscopy of the allocortex and isocortex in healthy children. AJNR Am J Neuroradiol 2000;21:1354–1358

    Abstract/FREE Full Text
29. ↵
    Lawler GA, Pennock JM, Steiner RE, Jenkins WJ, Sherlock S, Young IR. Nuclear magnetic resonance (NMR) imaging in Wilson disease. J Comput Assist Tomogr 1983;7:1–8

    PubMedWeb of Science
30. ↵
    Scheinberg IH, Sternlieb I. Wilson’s Disease. Philadelphia: W. B. Saunders;1984 :64–69
31. ↵
    Harper C, Butterworth R. Nutritional and metabolic disorders. In: Greenfield JG, Graham DI, Lantos PL, eds. Greenfield’s Neuropathology. 6th ed. New York: Oxford University Press;1997 :632–633
32. ↵
    De Stefano N, Matthews PM, Antel JP, Preul M, Francis G, Arnold DL. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995;38:901–909

    CrossRefPubMedWeb of Science
33. ↵
    De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995;34:721–727

    PubMedWeb of Science